Current strategies for managing CTEPH
M. Delcroix (Leuven, Belgium), J. Pepke-Zaba (Cambridge, United Kingdom), E. Fadel (Paris, France), D. Jenkins (Cambridge, United Kingdom), N. Kim (San Diego, United States of America), M. Madani (San Diego, United States of America), H. Matsubara (Okayama, Japan), G. Simonneau (Paris, France), E. Mayer (Bad-Bauheim, Germany), I. Lang (Vienna, Austria)
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Delcroix (Leuven, Belgium), J. Pepke-Zaba (Cambridge, United Kingdom), E. Fadel (Paris, France), D. Jenkins (Cambridge, United Kingdom), N. Kim (San Diego, United States of America), M. Madani (San Diego, United States of America), H. Matsubara (Okayama, Japan), G. Simonneau (Paris, France), E. Mayer (Bad-Bauheim, Germany), I. Lang (Vienna, Austria). Current strategies for managing CTEPH. 174
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: